EYLEA 3.6MG/90MICROLITRE SOLUTION FOR INJECTION
awardedWestern Health & Social Care Trust · GB-PPON-PTVW-2397-PWCT
Read the notice at Find a Tender ↗
Description
Supply of Eylea Brand of AFLIBERCEPT 40 mg/ml solution for injection in pre-filled syringe to meet clinical need in the Western Trust until 30/04/2027.
Key facts
- Procedure
- Direct award
- Lots
- 1
- Contact
- Bronagh HegartyInfo.Contracts@westerntrust.hscni.net02871345171 213760
- Contract period
- 10 Nov 2026 → 30 Apr 2027
- Value incl. VAT
- £210k
- Category
- goods
Awarded suppliers
- BAYER PUBLIC LIMITED COMPANY · GB-COH-00935048 · UKJ11, GB
Ground given for limiting competition
The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.
Continuity of patient care is required whilst clinicians complete assessment of the potential introduction of the contracted aflibercept biosimilar comparator. Established patients are currently treated with Eylea under existing treatment regimens. Continued supply of Eylea is required pending completion of clinical review, approval of any switching strategy, and implementation decisions.
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- Find a Tender
- Notice id
- 102318-2026
- OCID
- ocds-h6vhtk-0792e0
- First seen
- 28 Oct 2026
- Last updated
- 28 Oct 2026
Licence Open Government Licence v3.0 ↗
Contains public sector information licensed under the Open Government Licence v3.0. Source: Find a Tender.
GET /api/v1/tenders/01e13318-fd1c-4135-b781-473743eb2fb6The source notice is authoritative — verify deadlines and documents there before bidding.